Pharmaceutical Executive May 10, 2022
Industry has shown it can overcome challenges en route to creating new therapies.
Since 2000, the average time for new drug development is approximately 10 years. New anti-infective vaccine development, from clinical testing to approval, follows a similar timeline, taking anywhere from nine to 13 years. With the onset of COVID-19, however, development time was cut to just 11 months—for not one but three vaccines.
Of course, the circumstances weren’t ordinary. Solving problems without a clear solution has never gone faster. In fact, the only recent comparison would be that of the mumps virus in the 1960s; even then, the time to market was four years. In the past, there wasn’t a burning platform as significant as COVID.
However, some...
Today's Sponsors
Today's Sponsor